Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,236 | -12,437 | -13,104 | -9,064 | -6,185 |
| Depreciation Amortization | 3 | 13 | 10 | 6 | 3 |
| Accounts receivable | 8 | -6 | 1 | 2 | 2 |
| Accounts payable and accrued liabilities | 52 | N/A | -14 | 36 | 82 |
| Other Working Capital | -71 | -109 | -30 | 31 | 100 |
| Other Operating Activity | -60 | 10,709 | 11,620 | 8,074 | 5,701 |
| Operating Cash Flow | $-1,304 | $-1,829 | $-1,517 | $-916 | $-297 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,319 | N/A | N/A | 1,150 |
| Debt Repayment | -1,900 | -475 | -452 | -327 | -48 |
| Common Stock Issued | 14,437 | N/A | 3,319 | 1,919 | N/A |
| Other Financing Activity | -99 | 62 | 62 | 62 | 0 |
| Financing Cash Flow | $12,438 | $2,905 | $2,928 | $1,653 | $1,102 |
| Exchange Rate Effect | -1 | -20 | -15 | 9 | 2 |
| Beginning Cash Position | 2,045 | 990 | 990 | 990 | 990 |
| End Cash Position | 13,178 | 2,045 | 2,387 | 1,735 | 1,797 |
| Net Cash Flow | $11,134 | $1,055 | $1,397 | $736 | $805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,304 | -1,829 | -1,517 | -916 | -297 |
| Free Cash Flow | -1,304 | -1,829 | -1,517 | -916 | -297 |